Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells-Reference-Cited by-同舟云学术

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

Published:2005-08-08 Issue:41 Volume:24 Page:6213-6221
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Xia Wenle,Gerard Catherine M,Liu Leihua,Baudson Nathalie M,Ory Thierry L,Spector Neil L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208774.pdf

Reference51 articles.

1. Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, Pisacane PI, Lofgren JA, Tindell C, Evans DP, Maiese K, Scher HI and Sliwkowski MX . (2002). Cancer Cell, 2, 127–137.

2. Alimandi M, Romano A, Curia M, Muraro R, Fedi P, Aaronson SA, DiFiore PP and Kraus MH . (1995). Oncogene, 10, 1813–1821.

3. Arteaga CL . (2003). Exp. Cell Res., 284, 122–130.

4. Arteaga CL, O'Neil A, Moulder SL, Pins M, Sprano JA, Sledge GW and Davidson NE . (2004). Breast Cancer Res. Treat., 88 (Suppl.), 25a.

5. Bacus SS, Zelnich CR, Plowman G and Yarden Y . (1994). Am. J. Clin. Path., 102 (Suppl), S13–24.

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Synthesis and in vitro evaluation of 99mTc radiolabeled lapatinib (LPT) and its PLGA formulation;Journal of Radioanalytical and Nuclear Chemistry;2024-01-19

3. Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis;Current Oncology;2023-09-15

4. Targeting HER2/VEGFR2 dual tyrosine kinases with novel Lapatinib and Neratinib hybrid analogues lead to potential apoptotic induction in HER2 positive breast cancers: Design, synthesis, in-vitro, in-vivo and molecular docking studies.;2023-08-22

5. HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity;Breast Cancer Research and Treatment;2023-06-28